SENTIEN BIOTECHNOLOGIES, INC.

Basic Information

196 Boston Ave
MEDFORD, MA, 02155-4236

Company Profile

n/a

Additional Details

Field Value
DUNS: 828970900
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: N
Number of Employees: 4


  1. Stem Cell Bioreactor for Cardiac Care

    Amount: $1,012,556.00

    DESCRIPTION provided by applicant The goal of this Fast Track Phase I II SBIR is to test a novel extracorporeal system for delivering mesenchymal stem cell MSC secretions to treat acute myocardia ...

    SBIR Phase I 2016 Department of Health and Human Services National Institutes of Health
  2. Transforming Dialysis into a Controlled Drug Delivery System for Stem Cell Derive

    Amount: $2,985,949.00

    DESCRIPTION (provided by applicant): The goal of this Phase IIB SBIR application is to test the Sentien cellular bioreactor product (the Sentinel ) in a first-in-man study to assess safety and prelimi ...

    SBIR Phase II 2014 Department of Health and Human Services
  3. Transforming Dialysis into a Controlled Drug Delivery System for Stem Cell Derive

    Amount: $2,023,323.00

    DESCRIPTION provided by applicant The goal of this Phase IIB SBIR application is to test the Sentien cellular bioreactor product the Sentinelandquot in a first in man study to assess safety and ...

    SBIR Phase II 2014 Department of Health and Human Services National Institutes of Health
  4. Mesenchymal Stem Cell Bioreactor for the Active Treatment of Acute Renal Failure

    Amount: $773,285.00

    DESCRIPTION (provided by applicant): The overall goal of this project is to design a clinical protocol for the operation and monitoring of a mesenchymal stem cell (MSC)-coated dialysis device for the ...

    SBIR Phase II 2012 Department of Health and Human Services
  5. Blood Purification for Organ Failure

    Amount: $99,974.00

    Sentien Biotechnologies is developing cellular devices for the treatment of acute organ failure, including polytrauma-induced multiple organ dysfunction syndrome (MODS). Our flagship product, the Sent ...

    SBIR Phase I 2012 Department of Defense Army
  6. Cellular Device for the Treatment of Acute Liver Failure

    Amount: $499,306.00

    DESCRIPTION (provided by applicant): The goal of this Phase I project is to develop a cell-coated device for the treatment of acute liver failure. The device harnesses mesenchymal stem cell secretions ...

    SBIR Phase I 2012 Department of Health and Human Services
  7. A Mesenchymal Stem Cell Bioreactor for the Active Treatment of Acute Renal Failur

    Amount: $565,011.00

    DESCRIPTION (provided by applicant): The overall goal of this Phase I project is to create technical protocols for the reproducible operation of our proprietary cell-based device for the treatment of ...

    SBIR Phase I 2010 Department of Health and Human Services
  8. SBIR Phase I:Assembly and Storage of Cell-Derived Drug Delivery Devices

    Amount: $150,000.00

    This Small Business Innovation Research (SBIR) Phase I project proposes the development of a stem cell-based extracorporeal device that can offer unparalleled support to 200,000+ patients undergoing s ...

    SBIR Phase I 2010 National Science Foundation

Agency Micro-sites

US Flag An Official Website of the United States Government